| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.02. | Insplorion AB receives observation status | 253 | GlobeNewswire | Today, February 18, 2026, Insplorion AB (the "Company") disclosed its annual financial statement release for 2025 with information on the Company's financial situation.
According to item 6.3.1... ► Artikel lesen | |
| 18.02. | Insplorion AB: Year-end report 2025 | 442 | GlobeNewswire (Europe) | Outcome October- December
Outcome October- DecemberNet sales amounted to 297 (264) KsekProfit after financial items amounted to -16 221(-6 167133) kSEKEarnings per share before and after dilution: -0... ► Artikel lesen | |
| 11.02. | Insplorion AB: Insplorion has completed its strategic review and entered into an agreement in principle regarding the sale of its hydrogen sensor business to Mann Teknik AB for SEK 5.5 million | 347 | GlobeNewswire (Europe) | Insplorion AB (publ) ("Insplorion" or the "Company") today announces that the previously communicated strategic review has now been concluded and that the Company has entered into an agreement in principle... ► Artikel lesen | |
| 06.11.25 | Insplorion AB: Quarterly report Q3 2025 | 1.200 | GlobeNewswire (Europe) | July - September
Outcome July - SeptemberNet sales amounted to 926 (490) kSEKProfit after financial items amounted to -3,133 (-3,459) kSEKEarnings per share before and after dilution: SEK -0,04 (-0... ► Artikel lesen | |
| 03.11.25 | Insplorion AB: Insplorion announces management changes and initiates a strategic review | 542 | GlobeNewswire (Europe) | Insplorion AB (publ) ("Insplorion" or the "Company") announces that Johan Rask has decided to step down from his position as Chief Executive Officer (CEO). The Company's current Chief Product Officer... ► Artikel lesen | |
| INSPLORION Aktie jetzt für 0€ handeln | |||||
| 20.10.25 | Insplorion AB: Insplorion and MannTek signs Letter of Intent | 402 | GlobeNewswire (Europe) | Insplorion and MannTek sign a Letter of Intent (LOI) to explore integration of Insplorion's hydrogen sensing technology into MannTek's hydrogen refueling tank nozzels.
Insplorion's hydrogen sensing... ► Artikel lesen | |
| 29.08.25 | Insplorion AB: Quarterly report Q2 2025 | 1.326 | GlobeNewswire (Europe) | April - June
Outcome April - JuneNet sales amounted to 51 (160) KsekProfit after financial items amounted to -5 215 (-5 376) kSEKEarnings per share before and after dilution: SEK -0,09 (-0,23)Cash flow... ► Artikel lesen | |
| 04.08.25 | Insplorion AB: Update on Insplorion's strategic development and ongoing key initiatives | 639 | GlobeNewswire (Europe) | We are pleased to share a summary of recent developments at Insplorion. The update includes: (i) progress in our strategic collaboration with Consilium Safety Group, including a follow-up order valued... ► Artikel lesen | |
| 07.05.25 | Insplorion AB: Bulletin from Insplorion AB's Annual General Meeting 2025 | 1.068 | GlobeNewswire (Europe) | Today Insplorion AB held its Annual General Meeting. The AGM resolved on all points in accordance with the Board's and the Nomination Committee's proposals
The meeting approved the results and balance... ► Artikel lesen | |
| 05.05.25 | Insplorion AB: Insplorion officially launches the Insplorion NPS-P2 hydrogen detector | 990 | GlobeNewswire (Europe) | Insplorion, an innovative hydrogen sensor company, is proud to announce the official launch of the Insplorion NPS-P2 hydrogen detector.
The Insplorion NPS-P2 has been developed to detect hydrogen quickly... ► Artikel lesen | |
| 24.04.25 | Insplorion AB: Quarterly report Q1 2025 | 981 | GlobeNewswire (Europe) | January - March
Outcome January - MarchNet sales amounted to 604 (951) kSEKProfit after financial items amounted to -4,238 (-4,158) kSEKEarnings per share before and after dilution: SEK -0.09 (-0.20)... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FORMYCON | 21,500 | -3,80 % | Formycon erreicht Studienziel bei Keytruda-Biosimilar | Die Formycon AG hat für ihren Biosimilar-Kandidaten FYB206 positive klinische Daten gemeldet. In der Studie wurde nach Unternehmensangaben das primäre Ziel erreicht, indem eine pharmakokinetische Äquivalenz... ► Artikel lesen | |
| SOLESENCE | 1,290 | 0,00 % | Solésence, Inc.: Solésence Reports Third Quarter 2025 Financial Results | Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN)... ► Artikel lesen | |
| NANOVIRICIDES | 0,850 | +1,19 % | MPox Orphan Drug Designation Application Filed for NV-387, Declares NanoViricides | SHELTON, CONNECTICUT / ACCESS Newswire / February 12, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the... ► Artikel lesen | |
| GAUZY | 0,559 | 0,00 % | Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements | TEL AVIV, Israel, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ: GAUZ) ("Gauzy" or the "Company"), a global leader in vision and light control technologies, today announced that it has received... ► Artikel lesen | |
| VEECO INSTRUMENTS | 27,200 | -2,86 % | Veeco books multi-system Lumina and Spector orders for InP datacom laser manufacturing | ||
| ONTO INNOVATION | 178,00 | -4,81 % | ONTO INNOVATION INC. - 10-K, Annual Report | ||
| CANATU | 7,600 | -18,98 % | Canatu Oyj: Canatu's Financial Statements Bulletin 2025 | Canatu Plc Company announcement 3 March 2026 at 9:00 a.m. EET
Canatu's Financial Statements Bulletin 2025
This is a summary of Canatu Plc's Financial Statements Bulletin for the year 2025. The complete... ► Artikel lesen | |
| ZENTEK | 0,515 | -2,83 % | Zentek Ltd.: Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment | Albany Graphite uniquely positioned at intersection of NATO, federal, and provincial critical minerals mandates; Company accelerating path to Pre-Feasibility Study GUELPH, ON / ACCESS Newswire / February... ► Artikel lesen | |
| RIBER | 5,930 | -5,27 % | RIBER: 2025 performance driven by production systems and the rollout of ROSIE | 2025 performance driven by production systems and the rollout of ROSIE Revenues of €40.3 million in line with guidanceOrder book at December 31, 2025: €26.9 million (+24%) Bezons (France), February... ► Artikel lesen | |
| GOMSPACE | 1,644 | -1,67 % | GomSpace Group AB: GomSpace Reports an all-time high Q4 and a full year of significant growth | GomSpace delivers all-time high revenue, threefold growth in EBITDA, and secures major contracts for 2026, supported by a strong year-end balance sheet and cash position, as well as a 12% backlog increase... ► Artikel lesen | |
| NANOFORM FINLAND | 0,680 | -4,23 % | Nanoform Finland Oyj: The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees | Nanoform Finland Plc | Company Release | March 02, 2026 at 08:10:00 EET
Helsinki, Finland - The Annual General Meeting of Nanoform Finland Plc ("Nanoform") has on 15 April 2025 authorized the company's... ► Artikel lesen | |
| DOTZ NANO | 0,020 | +5,26 % | DOTZ NANO LIMITED: Notice of Annual General Meeting/Proxy Form | ||
| NVE | 58,50 | -1,68 % | Dividendenbekanntmachungen (02.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACUITY INC US00508Y1029 0,2 USD 0,1687 EUR ALLY FINANCIAL INC US02005N1000 0,3 USD 0,2531 EUR AMERISERV FINANCIAL INC US03074A1025 0... ► Artikel lesen | |
| NANOVEU | 0,043 | -9,20 % | NANOVEU LIMITED: Appendix 4G & Corporate Governance Statement | ||
| OBDUCAT | 0,004 | -36,36 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 31.12.2025 | Das Instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY wird cum Kapitalmassnahme gehandelt am 31.12.2025 und ex Kapitalmassnahme am 02.01.2026 The instrument OMAX SE0000722365 VIVESTO AB SK-,10 EQUITY... ► Artikel lesen |